This discussion uses Rousseau’s Emile to explicate Kohlberg’s characterization of moral development and to illuminate several theoretical problems for Kohlberg’s cognitive-developmental account. Their writings display remarkable similarities in the descriptions they give of moral growth, but they also reveal important disagreements about the relation of affect and cognition, the role of affect in development, the process of differentiation between developmental stages, the existence of conventional moral structures, and the nature of adult moral orientations. Analysis of these issues reinforces the importance of holistic approaches to affect, cognition, and the mechanisms of development, while implying that there are neither conventional nor adult stages of development. The analysis also supports contentions that Kohlberg’s concept of morality is unduly narrow and suggests that his one-sidedly rationalistic approach exaggerates the behavioral potential of moral education.

Keywords:
Adult development, Cognition, Developmental stages, Education, Emotional development, Moral development
This content is only available via PDF.
© 1983 S. Karger AG, Basel
1983
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.